drugset
drugset / Trial / NCT03896633

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

NCT03896633 ↗

Phase 1/2 Completed 637 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindHealth-services research

Summary

The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide compared with AzoptTM

Timeline

Start
2018-02-28
Primary completion
2018-11-17
Completion
2018-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule 1 % Topical

Indications

open-angle glaucoma